Article
Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
Journal of Alzheimer's disease : JAD - 1 Jan 2015
Armand-Ugón Mercedes, Aso Ester, Moreno Jesús, Riera-Codina Miquel, Sánchez Alex, Vegas Esteban, Ferrer Isidre
Abstract excerpt
Neuroprotection of erythropoietin (EPO) following long-term administration is hampered by the associated undesirable effects on hematopoiesis and body weight. For this reason, we tested carbamylated-EPO (CEPO), which has no effect on erythropoiesis, and compared it with EPO in the AβPP/PS1 mouse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
